34 research outputs found
Germina Natural vitro para fortalecer el sector agrĂcola
Con biotecnologĂa, la Universidad EAFIT apuesta por conservar la flora colombiana, mejorar la productividad agrĂcola y hacer negocios de conocimiento
Imágenes Ăłpticas más limpias gracias a los fĂsicos
A travĂ©s de una colaboraciĂłn con el Wellman Center for Photomedicine –de la Escuela de Medicina de Harvard y el Hospital General de Massachusetts–, EAFIT hizo su aporte para lograr suprimir manchas en la TomografĂa de Coherencia Ă“ptica (OCT). Esta correcciĂłn en la imagen contribuye a mejorar los diagnĂłsticos mĂ©dicos
JapĂłn otorga la primera patente internacional a Argos y EAFIT
El invento automatiza la mediciĂłn de cambios en el volumen del cemento. En febrero de 2017 se aprobĂł la patente en el paĂs oriental
Un matemático con perfil social
AndrĂ©s Mauricio Villegas es ingeniero matemático de EAFIT de la primera promociĂłn en 2007. Investiga en uno de los centros de ciencias actuariales más importantes del mundo, en Australia. La Universidad le otorgĂł el reconocimiento Egresados que Inspiran en la categorĂa de Ciencia, TecnologĂa e InnovaciĂłn. Actualmente, es docente de la Escuela de Riesgos y Estudios Actuariales (School of Risk And Acuarial Studies) e investigador asociado del Centro de Excelencia en InvestigaciĂłn para el Envejecimiento Poblacional (Cepar) de la Universidad de Nueva Gales del Sur (UNSW), en Sydney, Australia.AndrĂ©s Mauricio Villegas es ingeniero matemático de EAFIT de la primera promociĂłn en 2007. Investiga en uno de los centros de ciencias actuariales más importantes del mundo, en Australia. La Universidad le otorgĂł el reconocimiento Egresados que Inspiran en la categorĂa de Ciencia, TecnologĂa e InnovaciĂłn. Actualmente, es docente de la Escuela de Riesgos y Estudios Actuariales (School of Risk And Acuarial Studies) e investigador asociado del Centro de Excelencia en InvestigaciĂłn para el Envejecimiento Poblacional (Cepar) de la Universidad de Nueva Gales del Sur (UNSW), en Sydney, Australia
Conocimiento que protege vidas
​La avenida torrencial es un fenĂłmeno natural con alto potencial destructor y poco estudiado en el paĂs. CientĂficos de la Universidad EAFIT desarrollaron una metodologĂa para saber quĂ© zonas pueden verse afectadas. Es la primera vez, en Colombia, que se reportan datos sobre quĂ© tan antiguos serĂan estos eventos
Eafitenses inventan material para recubrir piezas industriales
An interdisciplinary team of the University developed a material in the form of coating, with high hardness, which makes it resistant to wear. For this invention, through Resolution 37510 of 2017, the Superintendence of Industry and Commerce granted EAFIT the 26 patent of 35 that it had until the end of 2017.Un equipo interdisciplinario de la Universidad desarrollĂł un material en forma de recubrimiento, con alta dureza, que lo hace resistente al desgaste. Por este invento, mediante ResoluciĂłn 37510 de 2017, la Superintendencia de Industria y Comercio le otorgĂł a EAFIT la patente 26, de 35 con que contaba hasta finales de 2017.
 
Eafitenses inventan material para recubrir piezas industriales
Un equipo interdisciplinario de la Universidad desarrollĂł un material en forma de recubrimiento, con alta dureza, que lo hace resistente al desgaste. Por este invento, mediante ResoluciĂłn 37510 de 2017, la Superintendencia de Industria y Comercio le otorgĂł a EAFIT la patente 26, de 35 con que contaba hasta finales de 2017
El videolaringoscopio, una creaciĂłn de la alianza Simdesign
La alianza Simdesign para innovar en salud, entre el Hospital Pablo Tobón Uribe y las universidades CES y EAFIT, dio origen a un nuevo dispositivo que resuelve una necesidad médica y sirve para el entrenamiento de estudiantes del área de la salud
JapĂłn otorga la primera patente internacional a Argos y EAFIT
The invention automates the measurement of changes in the volume of the cement. In February 2017 the patent was approved in the eastern country.El invento automatiza la mediciĂłn de cambios en el volumen del cemento. En febrero de 2017 se aprobĂł la patente en el paĂs oriental.
 
Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study
Summary
Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally.
Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies
have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of
the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income
countries globally, and identified factors associated with mortality.
Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to
hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis,
exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a
minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical
status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary
intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause,
in-hospital mortality for all conditions combined and each condition individually, stratified by country income status.
We did a complete case analysis.
Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital
diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal
malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middleincome
countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male.
Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3).
Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income
countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups).
Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome
countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries;
p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients
combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11],
p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20
[1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention
(ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety
checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed
(ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of
parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65
[0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality.
Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome,
middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will
be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger
than 5 years by 2030